Bioss Antibodies

Bioss Antibodies Leading antibody developer and manufacturer with 12,000+ targets and 300,000+ derived products.

Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 antigens/primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylat

ion, or methylation modifications. Our company promises fast delivery with strong, top quality scientific support. Bioss Inc is located in the greater Boston area of Massachusetts, the center of the world's largest and fastest growing biotech community. Our mission is to develop and manufacture top quality antibodies to accelerate biological research and discovery.

Presenting antibody-related research at a 2026 conference? Bioss is launching our 2026 Travel Grants to help get your re...
03/16/2026

Presenting antibody-related research at a 2026 conference? Bioss is launching our 2026 Travel Grants to help get your research there!

Whether you’re working in IHC, IF, ELISA, or assay development, we’d love to support your next presentation.

Submit your abstract here for a chance to win:
https://hubs.ly/Q046ZRhl0

Which conference is at the top of your list for 2026?

2026 Bioss Travel Grant

Working on Nipah virus studies? See our latest blog and explore Nipah virus-related recombinant proteins now available f...
01/29/2026

Working on Nipah virus studies? See our latest blog and explore Nipah virus-related recombinant proteins now available from Bioss.

View here: https://hubs.ly/Q040Wg2Z0

If you’re choosing between antibodies, citation history is often the fastest way to estimate:🔬 success probability📉 expe...
01/27/2026

If you’re choosing between antibodies, citation history is often the fastest way to estimate:

🔬 success probability
📉 experimental risk
🧪 reviewer confidence

Read the full breakdown in our new blog 👇

https://hubs.ly/Q040qYBZ0

We’re heading to Neuroscience 2025 in San Diego and we’d love to connect with you there!Join us at Booth 2318 to explore...
11/03/2025

We’re heading to Neuroscience 2025 in San Diego and we’d love to connect with you there!

Join us at Booth 2318 to explore our latest solutions for neuroscience research, including:

🧠 Recombinant & monoclonal antibodies
🧪 Biochemical compounds for neurobiology
⚙️ Custom antibody development

Whether you’re advancing neurodegeneration studies, synaptic biology, or neuroinflammation research, our team is here to help accelerate your discoveries!

📍 San Diego, CA
📅 November 2025
📎 Stop by, or message us to schedule a meeting in advance.

Let’s advance neuroscience together.

In the landscape of biomedical research, few methodologies have reshaped our comprehension of disease pathogenesis as fu...
10/31/2025

In the landscape of biomedical research, few methodologies have reshaped our comprehension of disease pathogenesis as fundamentally as immunohistochemistry (IHC).

This technique, which leverages antibody-antigen interactions to detect specific proteins within tissue sections, has become a cornerstone of diagnostic and investigative pathology.

Read more here: https://hubs.ly/Q03R8Vqt0

👉 Download your free booklet now and bring clarity and confidence to every IHC experiment: https://hubs.ly/Q03N-C4j0
10/17/2025

👉 Download your free booklet now and bring clarity and confidence to every IHC experiment: https://hubs.ly/Q03N-C4j0

This month’s IHC spotlight features CD11b, CD44, AIF1 (IBA1), and Ki-67— critical markers for tracking immune activation...
10/16/2025

This month’s IHC spotlight features CD11b, CD44, AIF1 (IBA1), and Ki-67— critical markers for tracking immune activation, inflammation, microglial response, and cell proliferation. Whether you're studying tumor progression, neuroinflammation, or regenerative biology, these antibodies offer the performance and specificity your research demands.

Click below to learn more:

CD11b - https://hubs.ly/Q03N-49j0
CD44 - https://hubs.ly/Q03N-2yv0
AIF1 - https://hubs.ly/Q03NZ_Py0
Ki-67 - https://hubs.ly/Q03N-1Hj0

When you look at a stained tissue sample and see high-contrast protein localization, that clarity is often thanks to HRP...
10/14/2025

When you look at a stained tissue sample and see high-contrast protein localization, that clarity is often thanks to HRP polymer detection.

HRP polymer detection replaces traditional methods with a biotin-free polymer backbone carrying dozens of HRP enzymes, delivering:

✅ Stronger signals with low background
✅ Simplified, time-saving workflow
✅ Reliable detection of low-abundance antigens

Whether you’re optimizing assays or refining your staining protocols, HRP polymer detection offers the precision and sensitivity needed to elevate your IHC results.

Read the full article to explore how it works and why it’s redefining immunohistochemistry: https://hubs.ly/Q03NycL60.

We're here to help you stretch your grant funding further with our Best Price offer! Take the most of your research budg...
09/17/2025

We're here to help you stretch your grant funding further with our Best Price offer! Take the most of your research budget now and submit a comparable lower-priced item to us for a discount to apply on your order!

🔗 https://hubs.ly/Q03JR51Z0

AI is transforming in vitro diagnostics (IVD) by accelerating the discovery and optimization of antibody pairs for ELISA...
09/16/2025

AI is transforming in vitro diagnostics (IVD) by accelerating the discovery and optimization of antibody pairs for ELISA, lateral flow assays, and multiplex platforms.

From predicting epitope binding to designing novel antibodies from scratch, AI is making diagnostics faster, smarter, and more precise.

👉 Explore how AI is reshaping the future of IVD antibody development: https://hubs.ly/Q03Jy03f0

A new study in Alzheimer’s & Dementia shows that drugs already used for Parkinson’s disease may improve memory and cogni...
09/08/2025

A new study in Alzheimer’s & Dementia shows that drugs already used for Parkinson’s disease may improve memory and cognition in Alzheimer’s patients. Could targeting dopamine be the next breakthrough for Alzheimer’s?

Learn more here: https://hubs.ly/Q03H8C_b0

Recombinant Proteins, Refined for Your Research 🧬 Our Recombinant Proteins are built to deliver:🔬 Lot-to-lot consistency...
09/04/2025

Recombinant Proteins, Refined for Your Research 🧬

Our Recombinant Proteins are built to deliver:

🔬 Lot-to-lot consistency
💎 High purity
📦 Formats that scale with your project

With 9,000+ recombinant proteins available, Bioss supports early discovery to large-scale workflows— without compromising performance.

Explore the collection: https://hubs.ly/Q03B01Kv0

Address

Boston, MA

Alerts

Be the first to know and let us send you an email when Bioss Antibodies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Bioss Antibodies:

Share